Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 203
Ph III recruiting: 21
Growth YoY: +3.8%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 101–150 of 163 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00381888	Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer	completed	Phase 2	44	Masonic Cancer Center, University of MinnesotaOTHER	1	Dec 28, 2017	clinicaltrials
NCT00610740	CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer	completed	Phase 2	18	Masonic Cancer Center, University of MinnesotaOTHER	1	Dec 28, 2017